Friday, May 29, 2009
In a lawsuit last month against drug manufacturer Merck, the plaintiff introduced a 'peer reviewed journal' strongly supportive of Merck drugs. The ‘journal’, it turned out, was paid for by Merck and its peer-review status was a fraud. Since then, six other journals have been revealed – all falsely identified as peer reviewed. Dr. Peter Lurie of Public Citizen explains how journal publishers and drug companies work together.
Hip HopArtist: Dead Prez